Neurones (XPAR:NRO) LT-Debt-to-Total-Asset: 0.04 (As of Dec. 2025)

What is Neurones LT-Debt-to-Total-Asset?

Neurones XPAR:NRO -1.82% 96 LT-Debt-to-Total-Asset is 0.04 as of Dec. 2025. GuruFocus rates XPAR:NRO with a GF Score™ of 96/100 and a GF Value™ of €50.31 (Significantly Undervalued). The stock has 3 warning signs investors should review.

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Neurones's long-term debt to total assests ratio for the quarter that ended in Dec. 2025 was 0.04.

Neurones's long-term debt to total assets ratio declined from Dec. 2024 (0.04) to Dec. 2025 (0.04). It may suggest that Neurones is progressively becoming less dependent on debt to grow their business.

Neurones (XPAR:NRO) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Neurones LT-Debt-to-Total-Asset Related Terms

Neurones LT-Debt-to-Total-Asset Historical Data

* Premium members only.

The historical data trend for Neurones's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Neurones LT-Debt-to-Total-Asset Chart

Neurones Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

0.05

0.04

0.05

0.04

Neurones Semi-Annual Data
	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24	Jun25	Dec25
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial															0.05	0.04	0.04	0.04	0.04

96GF Score

Neurones XPAR:NRO

LT-Debt-to-Total-Asset is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Neurones LT-Debt-to-Total-Asset Calculation

Neurones's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2025 is calculated as

LT Debt to Total Assets (A: Dec. 2025 )	=	Long-Term Debt & Capital Lease Obligation (A: Dec. 2025 )	/	Total Assets (A: Dec. 2025 )
	=	26.019	/	749.032
	=	0.03

Neurones's Long-Term Debt to Total Asset Ratio for the quarter that ended in Dec. 2025 is calculated as

LT Debt to Total Assets (Q: Dec. 2025 )	=	Long-Term Debt & Capital Lease Obligation (Q: Dec. 2025 )	/	Total Assets (Q: Dec. 2025 )
	=	26.019	/	749.032
	=	0.03

Frequently Asked Questions Learn more about LT-Debt-to-Total-Asset →

What does a LT-Debt-to-Total-Asset of 0.04 mean?

Neurones (XPAR:NRO) has a LT-Debt-to-Total-Asset of 0.04 as of Dec. 2025. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on Neurones and its competitors.

Is Neurones' LT-Debt-to-Total-Asset too high?

Neurones' current LT-Debt-to-Total-Asset is 0.04. Overall, Neurones has a GF Score™ of 96/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.

How does Neurones' LT-Debt-to-Total-Asset compare to IBM and ACN?

Neurones' LT-Debt-to-Total-Asset of 0.04 can be compared against companies in the Software industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good LT-Debt-to-Total-Asset for a Software company?

A good LT-Debt-to-Total-Asset depends on the Software industry context. However, LT-Debt-to-Total-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high LT-Debt-to-Total-Asset mean?

A high LT-Debt-to-Total-Asset can signal that a stock is expensive relative to its fundamentals. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on Neurones and its competitors. Neurones's current LT-Debt-to-Total-Asset is 0.04. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Neurones stock overvalued right now?

Based on GuruFocus' analysis, Neurones (XPAR:NRO) is currently considered Significantly Undervalued. The stock's GF Value™ is €50.31, compared to a current price of €35.00 — trading 30.4% below its estimated fair value. The current LT-Debt-to-Total-Asset is 0.04. Neurones' overall GF Score™ is 96/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is LT-Debt-to-Total-Asset calculated?

LT-Debt-to-Total-Asset is calculated from a company's financial statements. For Neurones (XPAR:NRO), the current LT-Debt-to-Total-Asset is 0.04 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Neurones (XPAR:NRO) Overvalued in 2026?

Based on GuruFocus' analysis, Neurones stock appears to be undervalued. The current stock price of €35.00 is trading 30.4% below its estimated GF Value™ of €50.31. GuruFocus considers Neurones to be Significantly Undervalued.

Key valuation signals for XPAR:NRO:

LT-Debt-to-Total-Asset: 0.04
GF Value™: €50.31 vs. price of €35.00 (30.4% below fair value)
GF Score™: 96/100 with 3 warning signs

No single metric tells the full story. See the XPAR:NRO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Neurones Business Description

Industry Technology Software

Comparable Companies XPAR:AUB XPAR:WAVE XPAR:ATO XPAR:INF XPAR:MLCHE XPAR:ALKEY XPAR:S30 XPAR:ALITL XPAR:ALHIT XPAR:FPG IBM NSE:TCS ACN NSE:INFY TSE:6702 TSE:6701 NSE:HCLTECH FISV XMAD:AMS FIS

Other Exchanges 0GX2:UK NE9:Germany

Address 205 Avenue Georges Clemenceau, Immeuble Le Clemenceau 1 Building, Nanterre, FRA, 92024

Website https://www.neurones.net

Neurones is active in Consulting and Digital Services, with activities including Digital Transformation, Overall Offer, Infrastructure Hub, Applications Hub, Consulting Division, Managed Services, and Service Centers. It also conducts IT development, pre-sales activities, management of fixed-price projects, technical assistance, infrastructure operations, and cybersecurity, and provides an internal platform for multi-LLM assistants, including Microsoft Copilot, ChatGPT, Gemini, Claude, and Mistral. Its segments are Infrastructure Services, Application Services, and Consulting. Infrastructure Services generates the majority of revenue and includes Cloud, Infrastructure Management, DevOps, Cybersecurity, User Support, IT Service Management, Information System Governance, and Automation.

96GF Score

Get the complete analysis for XPAR:NRO

LT-Debt-to-Total-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€35.00

Price

€50.31

GF Value

View XPAR:NRO Analysis

See LT-Debt-to-Total-Asset data for all stocks →